• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效且具选择性的血管紧张素转换酶2膦酰基肽抑制剂的研发。

Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.

作者信息

Mores Andreas, Matziari Magdalini, Beau Fabrice, Cuniasse Philippe, Yiotakis Athanasios, Dive Vincent

机构信息

Department of Chemistry, Laboratory of Organic Chemistry, University of Athens, Panepistimiopolis Zografou 15771, Athens, Greece.

出版信息

J Med Chem. 2008 Apr 10;51(7):2216-26. doi: 10.1021/jm701275z. Epub 2008 Mar 7.

DOI:10.1021/jm701275z
PMID:18324760
Abstract

Angiotensin-converting enzyme 2 (ACE2), a recently identified human homologue of angiotensin-converting enzyme, is a zinc metallocarboxypeptidase which may play a unique role in cardiovascular and renal function. Here we report the discovery of potent and selective inhibitors of ACE2, which have been identified by evaluating a series of phosphinic di- and tripeptides of the general formula: Z-Xaa(PO 2-CH 2)YaaOH and Ac-Zaa-Xaa(PO 2-CH 2)YaaOH. The most potent inhibitor in this series is a tripeptide that displays a K i value of 0.4 nM toward ACE2 and is 3 orders of magnitude less potent toward carboxypeptidase A. Phosphinic tripeptides exhibit high potency exclusively when the Xaa position is occupied by a pseudoproline. A model of interaction between one inhibitor of this series and ACE2 suggests that the critical role played by a proline in inhibitors, but also for substrates hydrolysis, may rely on the presence of Tyr (510) in the ACE2 active site.

摘要

血管紧张素转换酶2(ACE2)是最近发现的血管紧张素转换酶的人类同源物,是一种锌金属羧肽酶,可能在心血管和肾功能中发挥独特作用。在此我们报告了ACE2强效和选择性抑制剂的发现,这些抑制剂是通过评估一系列通式为:Z-Xaa(PO₂-CH₂)YaaOH和Ac-Zaa-Xaa(PO₂-CH₂)YaaOH的次膦酸二肽和三肽而确定的。该系列中最有效的抑制剂是一种三肽,其对ACE2的Ki值为0.4 nM,对羧肽酶A的效力低3个数量级。仅当Xaa位置被假脯氨酸占据时,次膦酸三肽才表现出高效力。该系列中一种抑制剂与ACE2之间的相互作用模型表明,脯氨酸在抑制剂中以及对底物水解所起的关键作用可能依赖于ACE2活性位点中Tyr (510)的存在。

相似文献

1
Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.高效且具选择性的血管紧张素转换酶2膦酰基肽抑制剂的研发。
J Med Chem. 2008 Apr 10;51(7):2216-26. doi: 10.1021/jm701275z. Epub 2008 Mar 7.
2
Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.RXPA380的结构决定因素,一种有效的且高度选择性的血管紧张素转换酶C结构域抑制剂。
Biochemistry. 2004 Jun 29;43(25):8048-54. doi: 10.1021/bi049504q.
3
Development of domain-selective angiotensin I-converting enzyme inhibitors.区域选择性血管紧张素I转换酶抑制剂的研发
Ann N Y Acad Sci. 2005 Nov;1056:160-75. doi: 10.1196/annals.1352.035.
4
The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.亮氨酸氨肽酶最有效的有机磷抑制剂。基于结构的设计、化学与活性。
J Med Chem. 2003 Jun 19;46(13):2641-55. doi: 10.1021/jm030795v.
5
RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.RXP 407是一种血管紧张素I转换酶N结构域的选择性抑制剂,可在体内阻断血液调节肽乙酰 - 丝氨酸 - 天冬氨酸 - 赖氨酸 - 脯氨酸的降解,而对血管紧张素I的水解没有影响。
J Pharmacol Exp Ther. 2001 May;297(2):606-11.
6
Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.膦三肽作为双重血管紧张素转换酶 C 域和内皮素转换酶 1 抑制剂。
J Med Chem. 2010 Jan 14;53(1):208-20. doi: 10.1021/jm9010803.
7
Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.基于结构的新型血管紧张素转换酶2抑制剂的药效团设计与虚拟筛选
J Chem Inf Model. 2006 Mar-Apr;46(2):708-16. doi: 10.1021/ci0503614.
8
Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme.高度特异性膦三肽对映异构体与血管紧张素转化酶复合物的晶体结构。
FEBS J. 2014 Feb;281(3):943-56. doi: 10.1111/febs.12660. Epub 2013 Dec 24.
9
RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.RXP 407是一种次膦酸肽,是一种能够区分血管紧张素I转换酶两个活性位点的强效抑制剂。
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4330-5. doi: 10.1073/pnas.96.8.4330.
10
Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.人血管紧张素转换酶-赖诺普利复合物的晶体结构
Nature. 2003 Jan 30;421(6922):551-4. doi: 10.1038/nature01370. Epub 2003 Jan 19.

引用本文的文献

1
Interactions of substrates and phosphinyl containing inhibitors with bacterial and human zinc proteases.底物及含磷酰基抑制剂与细菌和人类锌蛋白酶的相互作用。
PLoS One. 2025 Aug 1;20(8):e0329362. doi: 10.1371/journal.pone.0329362. eCollection 2025.
2
Targeting carboxypeptidase A/B activity with the phosphinic inhibitor C28 reduces the asthmatic response in a mouse model of house dust mite-induced asthma.使用次膦酸抑制剂C28靶向羧肽酶A/B的活性可减轻屋尘螨诱导的哮喘小鼠模型中的哮喘反应。
Inflamm Res. 2025 May 24;74(1):80. doi: 10.1007/s00011-025-02046-z.
3
Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor.
多形霉素型角鲨烯酮可预防 SARS-CoV-2 与 ACE2 受体结合。
Cells. 2022 Dec 25;12(1):83. doi: 10.3390/cells12010083.
4
Phosphinic Peptides as Tool Compounds for the Study of Pharmacologically Relevant Zn-Metalloproteases.次膦酸肽作为研究药理学相关锌金属蛋白酶的工具化合物。
ACS Pharmacol Transl Sci. 2022 Nov 28;5(12):1228-1253. doi: 10.1021/acsptsci.2c00183. eCollection 2022 Dec 9.
5
In Vitro Evaluation of In Silico Screening Approaches in Search for Selective ACE2 Binding Chemical Probes.体外评估 ACE2 结合化学探针虚拟筛选方法的研究
Molecules. 2022 Aug 24;27(17):5400. doi: 10.3390/molecules27175400.
6
Practical Synthesis of Phosphinic Dipeptides by Tandem Esterification of Aminophosphinic and Acrylic Acids under Silylating Conditions.硅烷化条件下通过氨基膦酸和丙烯酸的串联酯化反应实用合成膦酰二肽。
Molecules. 2022 Feb 12;27(4):1242. doi: 10.3390/molecules27041242.
7
Effect of an Inhibitor on the ACE2-Receptor-Binding Domain of SARS-CoV-2.抑制剂对 SARS-CoV-2 刺突蛋白受体结合域的影响。
J Chem Inf Model. 2022 Dec 26;62(24):6574-6585. doi: 10.1021/acs.jcim.1c01283. Epub 2022 Feb 4.
8
The identification of novel inhibitors of human angiotensin-converting enzyme 2 and main protease of Sars-Cov-2: A combination of methods for treatment of COVID-19.新型人类血管紧张素转换酶2和新冠病毒主要蛋白酶抑制剂的鉴定:治疗新冠肺炎的联合方法
J Mol Struct. 2021 Aug 5;1237:130409. doi: 10.1016/j.molstruc.2021.130409. Epub 2021 Apr 6.
9
Cyclic Ga-Labeled Peptides for Specific Detection of Human Angiotensin-Converting Enzyme 2.用于特异性检测人血管紧张素转换酶 2 的环状 Ga 标记肽。
J Nucl Med. 2021 Nov;62(11):1631-1637. doi: 10.2967/jnumed.120.261768. Epub 2021 Feb 26.
10
ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.ACE2 和 ACE:基于结构的 SARS-CoV 机制、调控和受体识别的见解。
Clin Sci (Lond). 2020 Nov 13;134(21):2851-2871. doi: 10.1042/CS20200899.